Around 90 percent of all cancers are so-called solid tumors – growths that form dense tissue. Many of them remain difficult to treat. Researchers at TU Dresden have genetically modified immune cells so that they can penetrate deep into tumor tissue and potentially attack cancer cells over the long term. The EU is now funding the project with 2.5 million euros.
Good Newsletter von DieSachsen.de
Good Newsletter von DieSachsen.de
Articles are loaded
Your data is important to us and we would like to use cookies to further improve your incredible experience on DieSachsen.de.
